Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Rises By 181.6%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 105,600 shares, a growth of 181.6% from the November 30th total of 37,500 shares. Based on an average daily volume of 133,500 shares, the short-interest ratio is currently 0.8 days.

Tevogen Bio Stock Performance

Shares of TVGNW traded up $0.01 during trading hours on Friday, hitting $0.06. 105,149 shares of the company were exchanged, compared to its average volume of 66,462. The firm’s 50 day moving average is $0.06 and its 200-day moving average is $0.04. Tevogen Bio has a 52 week low of $0.01 and a 52 week high of $0.28.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.